PrIMAVeRa project publishes on contact network dynamics to prevent pathogen transmission in hospitals
Activities continue in the PrIMAVeRa project, with the latest result being the publication of a new manuscript titled “Using contact...
top of page
Newsroom
Check on PrIMAVeRa's latest news
- Jun 25
PrIMAVeRa project advances in combating AMR: key insights from year two progress review meeting
Divided into two rounds during June, Consortium partners presented year two progress to SAC.
35
- May 15
PrIMAVeRa project partners present posters at ECCMID 2024
The team shared challenges & solutions for data-sharing & re-use, and expert consensus on priorities for vaccine/mAb R&D and implementation.
26
- Mar 8
PrIMAVeRa participates in AMR Accelerator Cross-Project Meeting 2024
The Cross-Project Meeting gathered nearly 40 participants representing 9 IHI-funded projects from the AMR Accelerator, in Basel, Switzerland
114
- Nov 24, 2023
PrIMAVeRa provides in-depth reports on current evidence base of burden of AMR in Europe
The PrIMAVeRa project proudly announces the simultaneous publication of four informative systematic reviews.
237
- Nov 24, 2023
PrIMAVeRa 2nd annual meeting successfully held in hybrid format in Utrecht on 15-16 November 2023
The meeting enabled dynamic panel discussions covering the burden of AMR, and model development and data access.
189
- Jun 19, 2023
PrIMAVeRa Project Appoints Scientific Advisory Committee
The PrIMAVeRa project announces the appointment of the Scientific Advisory Committee (SAC).
91
- Nov 30, 2022
PrIMAVeRa 1st annual meeting successfully held in a hybrid event in Verona on 29-30 November 2022
PrIMAVeRa team gathered for the first project annual meeting with around 30 project partners joining in Verona (IT), and virtually.
105
- Feb 3, 2022
PrIMAVeRa WP2 workshop, virtually held on 27-28 January 2022
The 2-day workshop included an overview of WP2, presentation and discussion of AMR case studies, the draft of AMR protocol, and more.
207
- Dec 15, 2021
PrIMAVeRa kick-off meeting successfully marks the official project launch
The PrIMAVeRa consortium held its Kick-off Meeting on 25 November 2021 marking the official launch of this ambitious endeavor.
76
- Nov 9, 2021
PrIMAVeRa, an ambitious project to demonstrate how vaccines can combat AMR
The IMI2 Joint Undertaking mobilises more than € 9 million to harnessing the power of big data and AI to steer the fight against AMR
67
bottom of page